Complex multidrug therapy in a patient with pulmonary hypertension before and after orthotopic heart transplantation. A case report

Journal of Cardiovascular Medicine

Volumn 8, Issue 11, 2007, Pages 950-952

  D'Alto, Michele ^a,b   Alfano, Dionigia ^a   Maiello, Ciro ^a   Sarubbi, Berardo ^a   Santoro, Giuseppe ^a   Argiento, Paola ^a   Galdieri, Nicola ^a   Russo, Maria G ^a   Cotrufo, Maurizio ^a   Calabrò, Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Heart transplantation; Pulmonary hypertension; Therapy

Indexed keywords

BOSENTAN; CYCLOSPORIN; ILOPROST; PROSTACYCLIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CLUBBING FINGERS; CONVALESCENCE; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART FAILURE; HEART FUNCTION; HEART MURMUR; HEART SOUND; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LUNG HEMODYNAMICS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PHYSICAL EXAMINATION; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; THORAX RADIOGRAPHY;

ADULT; ANTIHYPERTENSIVE AGENTS; CARDIOMYOPATHY, RESTRICTIVE; DRUG THERAPY, COMBINATION; EPOPROSTENOL; HEART CATHETERIZATION; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; SULFONAMIDES;

EID: 34948831978     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328013fa50     Document Type: Article

References (9)

1. Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, et al. Mild vs. severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant 2005; 24:998-1007.
2. Lee SH, Rubin LJ. Current treatment strategies for pulmonary arterial hypertension. J Intern Med 2005; 258:199-215.
3. Brauchlin AE, Soccal PM, Rochat T, Spiliopoulos A, Nicod LP, Trindade PT. Severe left ventricular dysfunction secondary to primary pulmonary hypertension: bridging therapy with bosentan before lung transplantation. J Heart Lung Transplant 2005; 24:777-780.
4. Gomez-Moreno S, Lage E, Hernandez A, Campos A, Cabezon S, Ordonez A, et al. Use of oral sildenafil in patients with irreversible pulmonary hypertension not eligible for heart transplantation. Transplant Proc 2005; 37:1550-1551.
5. Lepore JJ, Dec GW, Zapol WM, Bloch KD, Semigran MJ. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients. J Heart Lung Transplant 2005; 24:1950-1956.
6. Radovancevic B, Vrtovec B, Thomas CD, Croitoru M, Myers TJ, Radovancevic R, et al. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. J Heart Lung Transplant 2005; 24:690-695.
7. Borbely A, van der Velden J, Papp Z, Bronzwaer JGF, Edes I, Stienen GJ, et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111:774-781.
8. Ardehali H, Kasper EK, Baughman KL. Diagnostic approach to the patient with cardiomyopathy: whom to biopsy. Am Heart J 2005; 149:7-12.
9. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al., for the Myocarditis Treatment Trial Investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995; 333:269-275.